HomeCompareRASP vs DIVO

RASP vs DIVO: Dividend Comparison 2026

RASP yields 400000.00% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RASP wins by $5.011119029548644e+32M in total portfolio value
10 years
RASP
RASP
● Live price
400000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.011119029548644e+32M
Annual income
$500,865,583,351,836,840,000,000,000,000,000,000,000.00
Full RASP calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — RASP vs DIVO

📍 RASP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRASPDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RASP + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RASP pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RASP
Annual income on $10K today (after 15% tax)
$34,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, RASP beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RASP + DIVO for your $10,000?

RASP: 50%DIVO: 50%
100% DIVO50/50100% RASP
Portfolio after 10yr
$2.505559514774322e+32M
Annual income
$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr
Blended yield
99.95%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RASP buys
0
DIVO buys
0
No recent congressional trades found for RASP or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRASPDIVO
Forward yield400000.00%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$5.011119029548644e+32M$30.7K
Annual income after 10y$500,865,583,351,836,840,000,000,000,000,000,000,000.00$981.68
Total dividends collected$5.010957816668433e+32M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RASP vs DIVO ($10,000, DRIP)

YearRASP PortfolioRASP Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$40,010,700$40,000,000.00$11,349$649.42+$40.00MRASP
2$149,615,521,729$149,572,710,280.37$12,833$688.83+$149615.51MRASP
3$522,880,052,725,200$522,719,964,116,949.25$14,459$727.90+$522880052.71MRASP
4$1,707,862,989,289,045,000$1,707,303,507,632,628,700.00$16,238$766.49+$1707862989289.03MRASP
5$5,213,509,402,845,684,000,000$5,211,681,989,447,144,000,000.00$18,179$804.47+$5213509402845684.00MRASP
6$14,874,219,058,409,543,000,000,000$14,868,640,603,348,497,000,000,000.00$20,293$841.71+$14874219058409543680.00MRASP
7$39,661,196,234,050,755,000,000,000,000$39,645,280,819,658,260,000,000,000,000.00$22,591$878.14+$3.966119623405075e+22MRASP
8$98,838,436,350,327,300,000,000,000,000,000$98,795,998,870,356,880,000,000,000,000,000.00$25,087$913.65+$9.88384363503273e+25MRASP
9$230,205,236,474,344,900,000,000,000,000,000,000$230,099,479,347,450,050,000,000,000,000,000,000.00$27,791$948.18+$2.302052364743449e+29MRASP
10$501,111,902,954,864,400,000,000,000,000,000,000,000$500,865,583,351,836,840,000,000,000,000,000,000,000.00$30,718$981.68+$5.011119029548644e+32MRASP

RASP vs DIVO: Complete Analysis 2026

RASPStock

Actavia Life Sciences, Inc. is a biotechnology company, which engages in the development of therapeutics for the treatment of leukemia and lymphoma diseases. It also develops small molecule drug candidates that focus on treating acute myeloid leukemia. The company was founded in 2013 and is headquartered in New York, NY.

Full RASP Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this RASP vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RASP vs SCHDRASP vs JEPIRASP vs ORASP vs KORASP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.